Abstract and Introduction Rationale for i.v. Antihypertensive Selection Clinical Pharmacology of i.v. Antihypertensives References There are potential concerns with the use of sodium nitroprusside ...
Normally, hospitals are, well, flush with IV fluids. But right now, that isn’t the case. In addition to the physical damage to many hospitals and clinics in the region, Hurricane Helene knocked ...
IV fluid supply disruptions prompt Biden administration to invoke wartime powers to bolster recovery
The major disruptions to the IV fluid supply after Hurricane Helene are the latest in a string of challenges that have exposed vulnerabilities to the broader US supply chain. There were a record ...
An over-the-counter medication sold today as Zantac 360 by Sanofi has a different active ingredient from the withdrawn versions of Zantac and has not raised questions about a cancer link.
A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...
The Biden administration says it has invoked the wartime powers of the Defense Production Act to speed rebuilding of a major American factory of intravenous fluids that was wrecked by Hurricane ...
Corrects headline to say 'settlements' instead of 'settlement' British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits ...
British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug. GSK suffered ...
GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to allegations that its old reflux medication Zantac was contaminated with a suspected carcinogen.
GSK to pay $70 million to settle whistleblower lawsuit Pfizer and Sanofi also settling Zantac cases Boehringer Ingelheim faces trial, denies wrongdoing Oct 9 (Reuters) - GSK (GSK.L), opens new tab ...
Dupixent has interactions with some other drugs. Examples include certain seizure medications, warfarin, and certain heart medications. Dupixent is prescribed for the following conditions in ...
Although not Federal Drug Administration-approved for treatment of UGI bleeding, intravenous pantoprazole is being used for this condition as a non-formulary indication. PPI therapy is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback